Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107898904 | 10789890 | 4 | F | 20141012 | 20160628 | 20150212 | 20160701 | EXP | PHHY2014JP144011 | NOVARTIS | 67.71 | YR | F | Y | 41.00000 | KG | 20160701 | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107898904 | 10789890 | 1 | PS | AFINITOR | EVEROLIMUS | 1 | Oral | 10 MG, QD | 810 | MG | Y | 22334 | 10 | MG | TABLET | QD | |||
| 107898904 | 10789890 | 2 | SS | PREDONINE | PREDNISOLONEPREDNISOLONE ACETATEPREDNISOLONE SODIUM SUCCINATE | 1 | Oral | 40 MG, UNK | Y | 0 | 40 | MG | |||||||
| 107898904 | 10789890 | 3 | SS | PREDONINE | PREDNISOLONEPREDNISOLONE ACETATEPREDNISOLONE SODIUM SUCCINATE | 1 | Oral | 35 MG, UNK | Y | 0 | 35 | MG | |||||||
| 107898904 | 10789890 | 4 | SS | PREDONINE | PREDNISOLONEPREDNISOLONE ACETATEPREDNISOLONE SODIUM SUCCINATE | 1 | Oral | 30 MG, UNK | Y | 0 | 30 | MG | |||||||
| 107898904 | 10789890 | 5 | SS | PREDONINE | PREDNISOLONEPREDNISOLONE ACETATEPREDNISOLONE SODIUM SUCCINATE | 1 | Oral | 20 MG, UNK | Y | 0 | 20 | MG | |||||||
| 107898904 | 10789890 | 6 | SS | PREDONINE | PREDNISOLONEPREDNISOLONE ACETATEPREDNISOLONE SODIUM SUCCINATE | 1 | Oral | 17 MG, UNK | Y | 0 | 17 | MG | |||||||
| 107898904 | 10789890 | 7 | SS | PREDONINE | PREDNISOLONEPREDNISOLONE ACETATEPREDNISOLONE SODIUM SUCCINATE | 1 | Oral | 15 MG, UNK | Y | 0 | 15 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 107898904 | 10789890 | 1 | Breast cancer metastatic |
| 107898904 | 10789890 | 2 | Pneumocystis jirovecii pneumonia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 107898904 | 10789890 | DS |
| 107898904 | 10789890 | HO |
| 107898904 | 10789890 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 107898904 | 10789890 | Body temperature increased | |
| 107898904 | 10789890 | Cough | |
| 107898904 | 10789890 | Decreased appetite | |
| 107898904 | 10789890 | Decreased immune responsiveness | |
| 107898904 | 10789890 | Depression | |
| 107898904 | 10789890 | Diabetes mellitus inadequate control | |
| 107898904 | 10789890 | Dyspnoea | |
| 107898904 | 10789890 | Hyperglycaemia | |
| 107898904 | 10789890 | Interstitial lung disease | |
| 107898904 | 10789890 | Pneumocystis jirovecii pneumonia | |
| 107898904 | 10789890 | Pneumomediastinum | |
| 107898904 | 10789890 | Pneumothorax | |
| 107898904 | 10789890 | Pulmonary alveolar haemorrhage | |
| 107898904 | 10789890 | Subcutaneous emphysema | |
| 107898904 | 10789890 | Tachycardia | |
| 107898904 | 10789890 | Tachypnoea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 107898904 | 10789890 | 1 | 20140808 | 20141027 | 0 | |
| 107898904 | 10789890 | 2 | 20141029 | 20141103 | 0 | |
| 107898904 | 10789890 | 3 | 20141104 | 20141110 | 0 | |
| 107898904 | 10789890 | 4 | 20141111 | 20141117 | 0 | |
| 107898904 | 10789890 | 5 | 20141118 | 20141130 | 0 | |
| 107898904 | 10789890 | 6 | 20141201 | 20141214 | 0 | |
| 107898904 | 10789890 | 7 | 20141215 | 0 |